APA (7th ed.) Citation
(2026). Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes. ACR Open Rheumatology.
Chicago Style (17th ed.) Citation
"Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes." ACR Open Rheumatology 2026.
MLA (9th ed.) Citation
"Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes." ACR Open Rheumatology, 2026.
Warning: These citations may not always be 100% accurate.